The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/39315
StudyName: Eligibility First Line Metastatic Breast Cancer NCT01303679
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 18.12.2019
License: Creative Commons BY 4.0

----

Description: 
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303679
